Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | 7 | 1 |
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1902554 | serine/threonine protein kinase complex | 6 | 1 |
GO:1902911 | protein kinase complex | 5 | 1 |
GO:1990234 | transferase complex | 3 | 1 |
Related structures:
AlphaFold database: E9B0D3
Term | Name | Level | Count |
---|---|---|---|
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 6 | 1 |
GO:0001932 | regulation of protein phosphorylation | 7 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019220 | regulation of phosphate metabolic process | 6 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0022402 | cell cycle process | 2 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031399 | regulation of protein modification process | 6 | 1 |
GO:0042325 | regulation of phosphorylation | 7 | 1 |
GO:0043549 | regulation of kinase activity | 5 | 1 |
GO:0044770 | cell cycle phase transition | 3 | 1 |
GO:0044772 | mitotic cell cycle phase transition | 4 | 1 |
GO:0045859 | regulation of protein kinase activity | 6 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050790 | regulation of catalytic activity | 3 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051174 | regulation of phosphorus metabolic process | 5 | 1 |
GO:0051246 | regulation of protein metabolic process | 5 | 1 |
GO:0051338 | regulation of transferase activity | 4 | 1 |
GO:0051726 | regulation of cell cycle | 4 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065009 | regulation of molecular function | 2 | 1 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 7 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1903047 | mitotic cell cycle process | 3 | 1 |
GO:1904029 | regulation of cyclin-dependent protein kinase activity | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 5 | 1 |
GO:0019207 | kinase regulator activity | 3 | 1 |
GO:0019887 | protein kinase regulator activity | 4 | 1 |
GO:0030234 | enzyme regulator activity | 2 | 1 |
GO:0098772 | molecular function regulator activity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 131 | 135 | PF00656 | 0.292 |
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.511 |
CLV_NRD_NRD_1 | 283 | 285 | PF00675 | 0.581 |
CLV_NRD_NRD_1 | 417 | 419 | PF00675 | 0.496 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.493 |
CLV_PCSK_KEX2_1 | 283 | 285 | PF00082 | 0.576 |
CLV_PCSK_KEX2_1 | 359 | 361 | PF00082 | 0.385 |
CLV_PCSK_KEX2_1 | 417 | 419 | PF00082 | 0.496 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.557 |
CLV_PCSK_PC1ET2_1 | 359 | 361 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 283 | 287 | PF00082 | 0.559 |
CLV_PCSK_SKI1_1 | 359 | 363 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 388 | 392 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.469 |
CLV_PCSK_SKI1_1 | 73 | 77 | PF00082 | 0.508 |
DEG_APCC_DBOX_1 | 264 | 272 | PF00400 | 0.439 |
DOC_CYCLIN_yCln2_LP_2 | 19 | 25 | PF00134 | 0.471 |
DOC_MAPK_gen_1 | 51 | 61 | PF00069 | 0.322 |
DOC_MAPK_MEF2A_6 | 218 | 225 | PF00069 | 0.386 |
DOC_MAPK_MEF2A_6 | 89 | 97 | PF00069 | 0.298 |
DOC_USP7_MATH_1 | 203 | 207 | PF00917 | 0.414 |
DOC_USP7_UBL2_3 | 355 | 359 | PF12436 | 0.570 |
DOC_USP7_UBL2_3 | 47 | 51 | PF12436 | 0.349 |
DOC_WW_Pin1_4 | 349 | 354 | PF00397 | 0.551 |
LIG_14-3-3_CanoR_1 | 218 | 224 | PF00244 | 0.430 |
LIG_14-3-3_CanoR_1 | 265 | 275 | PF00244 | 0.412 |
LIG_14-3-3_CanoR_1 | 333 | 338 | PF00244 | 0.444 |
LIG_14-3-3_CanoR_1 | 89 | 94 | PF00244 | 0.351 |
LIG_14-3-3_CterR_2 | 417 | 420 | PF00244 | 0.627 |
LIG_Actin_WH2_2 | 126 | 143 | PF00022 | 0.290 |
LIG_Actin_WH2_2 | 75 | 91 | PF00022 | 0.290 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.451 |
LIG_BRCT_BRCA1_1 | 16 | 20 | PF00533 | 0.477 |
LIG_eIF4E_1 | 181 | 187 | PF01652 | 0.378 |
LIG_EVH1_1 | 400 | 404 | PF00568 | 0.616 |
LIG_EVH1_2 | 403 | 407 | PF00568 | 0.613 |
LIG_FHA_1 | 172 | 178 | PF00498 | 0.308 |
LIG_FHA_1 | 267 | 273 | PF00498 | 0.419 |
LIG_FHA_1 | 320 | 326 | PF00498 | 0.380 |
LIG_FHA_1 | 372 | 378 | PF00498 | 0.590 |
LIG_FHA_1 | 74 | 80 | PF00498 | 0.278 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.268 |
LIG_FHA_2 | 295 | 301 | PF00498 | 0.421 |
LIG_FHA_2 | 325 | 331 | PF00498 | 0.327 |
LIG_FHA_2 | 391 | 397 | PF00498 | 0.647 |
LIG_GBD_Chelix_1 | 176 | 184 | PF00786 | 0.458 |
LIG_IRF3_LxIS_1 | 365 | 372 | PF10401 | 0.578 |
LIG_LIR_Apic_2 | 36 | 41 | PF02991 | 0.471 |
LIG_LIR_Gen_1 | 219 | 225 | PF02991 | 0.402 |
LIG_LIR_Gen_1 | 250 | 261 | PF02991 | 0.317 |
LIG_LIR_Gen_1 | 303 | 310 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 312 | 321 | PF02991 | 0.357 |
LIG_LIR_Gen_1 | 330 | 338 | PF02991 | 0.225 |
LIG_LIR_Gen_1 | 43 | 53 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 165 | 170 | PF02991 | 0.304 |
LIG_LIR_Nem_3 | 219 | 223 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 250 | 256 | PF02991 | 0.313 |
LIG_LIR_Nem_3 | 303 | 307 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 312 | 317 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 330 | 334 | PF02991 | 0.259 |
LIG_PCNA_PIPBox_1 | 232 | 241 | PF02747 | 0.444 |
LIG_Pex14_2 | 256 | 260 | PF04695 | 0.378 |
LIG_PTB_Apo_2 | 175 | 182 | PF02174 | 0.304 |
LIG_PTB_Phospho_1 | 175 | 181 | PF10480 | 0.304 |
LIG_SH2_CRK | 335 | 339 | PF00017 | 0.444 |
LIG_SH2_PTP2 | 304 | 307 | PF00017 | 0.387 |
LIG_SH2_SRC | 170 | 173 | PF00017 | 0.394 |
LIG_SH2_SRC | 38 | 41 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.252 |
LIG_SH2_STAT5 | 304 | 307 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 337 | 340 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 413 | 416 | PF00017 | 0.599 |
LIG_SH3_1 | 398 | 404 | PF00018 | 0.571 |
LIG_SH3_3 | 398 | 404 | PF00018 | 0.630 |
LIG_SUMO_SIM_anti_2 | 2 | 10 | PF11976 | 0.455 |
LIG_SUMO_SIM_anti_2 | 206 | 211 | PF11976 | 0.380 |
LIG_SUMO_SIM_anti_2 | 219 | 227 | PF11976 | 0.364 |
LIG_SUMO_SIM_anti_2 | 57 | 63 | PF11976 | 0.320 |
LIG_SUMO_SIM_par_1 | 142 | 148 | PF11976 | 0.331 |
LIG_SUMO_SIM_par_1 | 203 | 208 | PF11976 | 0.372 |
LIG_TRAF2_1 | 158 | 161 | PF00917 | 0.362 |
LIG_UBA3_1 | 44 | 51 | PF00899 | 0.331 |
LIG_WRC_WIRS_1 | 163 | 168 | PF05994 | 0.262 |
MOD_CDC14_SPxK_1 | 352 | 355 | PF00782 | 0.650 |
MOD_CDK_SPxK_1 | 349 | 355 | PF00069 | 0.555 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.484 |
MOD_CK1_1 | 227 | 233 | PF00069 | 0.412 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.424 |
MOD_CK1_1 | 309 | 315 | PF00069 | 0.190 |
MOD_CK1_1 | 336 | 342 | PF00069 | 0.369 |
MOD_CK1_1 | 57 | 63 | PF00069 | 0.374 |
MOD_CK2_1 | 192 | 198 | PF00069 | 0.418 |
MOD_CK2_1 | 294 | 300 | PF00069 | 0.433 |
MOD_CK2_1 | 324 | 330 | PF00069 | 0.328 |
MOD_CK2_1 | 390 | 396 | PF00069 | 0.635 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.614 |
MOD_GlcNHglycan | 311 | 314 | PF01048 | 0.586 |
MOD_GlcNHglycan | 370 | 374 | PF01048 | 0.392 |
MOD_GSK3_1 | 288 | 295 | PF00069 | 0.429 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.442 |
MOD_N-GLC_1 | 246 | 251 | PF02516 | 0.467 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.440 |
MOD_NEK2_1 | 239 | 244 | PF00069 | 0.396 |
MOD_NEK2_1 | 245 | 250 | PF00069 | 0.457 |
MOD_NEK2_1 | 255 | 260 | PF00069 | 0.309 |
MOD_NEK2_1 | 286 | 291 | PF00069 | 0.356 |
MOD_NEK2_1 | 369 | 374 | PF00069 | 0.563 |
MOD_NEK2_1 | 382 | 387 | PF00069 | 0.511 |
MOD_NEK2_1 | 407 | 412 | PF00069 | 0.618 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.279 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.286 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.270 |
MOD_NEK2_2 | 162 | 167 | PF00069 | 0.266 |
MOD_PIKK_1 | 192 | 198 | PF00454 | 0.492 |
MOD_PIKK_1 | 224 | 230 | PF00454 | 0.233 |
MOD_PIKK_1 | 289 | 295 | PF00454 | 0.465 |
MOD_PIKK_1 | 319 | 325 | PF00454 | 0.381 |
MOD_PIKK_1 | 371 | 377 | PF00454 | 0.592 |
MOD_PKA_2 | 300 | 306 | PF00069 | 0.363 |
MOD_PKA_2 | 407 | 413 | PF00069 | 0.587 |
MOD_PKA_2 | 88 | 94 | PF00069 | 0.361 |
MOD_Plk_1 | 57 | 63 | PF00069 | 0.391 |
MOD_Plk_4 | 162 | 168 | PF00069 | 0.295 |
MOD_Plk_4 | 172 | 178 | PF00069 | 0.317 |
MOD_Plk_4 | 219 | 225 | PF00069 | 0.423 |
MOD_Plk_4 | 248 | 254 | PF00069 | 0.409 |
MOD_Plk_4 | 267 | 273 | PF00069 | 0.341 |
MOD_Plk_4 | 300 | 306 | PF00069 | 0.376 |
MOD_Plk_4 | 333 | 339 | PF00069 | 0.418 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.436 |
MOD_Plk_4 | 62 | 68 | PF00069 | 0.274 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.391 |
MOD_ProDKin_1 | 349 | 355 | PF00069 | 0.555 |
MOD_SUMO_for_1 | 128 | 131 | PF00179 | 0.290 |
MOD_SUMO_for_1 | 34 | 37 | PF00179 | 0.509 |
MOD_SUMO_rev_2 | 352 | 361 | PF00179 | 0.539 |
MOD_SUMO_rev_2 | 36 | 44 | PF00179 | 0.442 |
TRG_DiLeu_BaEn_1 | 357 | 362 | PF01217 | 0.592 |
TRG_DiLeu_LyEn_5 | 357 | 362 | PF01217 | 0.592 |
TRG_ENDOCYTIC_2 | 181 | 184 | PF00928 | 0.306 |
TRG_ENDOCYTIC_2 | 304 | 307 | PF00928 | 0.387 |
TRG_ENDOCYTIC_2 | 335 | 338 | PF00928 | 0.444 |
TRG_ER_diArg_1 | 283 | 285 | PF00400 | 0.388 |
TRG_ER_diArg_1 | 417 | 419 | PF00400 | 0.696 |
TRG_ER_diArg_1 | 72 | 74 | PF00400 | 0.335 |
TRG_NES_CRM1_1 | 136 | 148 | PF08389 | 0.309 |
TRG_Pf-PMV_PEXEL_1 | 141 | 145 | PF00026 | 0.561 |
TRG_Pf-PMV_PEXEL_1 | 77 | 81 | PF00026 | 0.531 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8P2 | Leptomonas seymouri | 80% | 100% |
A0A0S4JZZ8 | Bodo saltans | 45% | 99% |
A0A1X0P2F8 | Trypanosomatidae | 45% | 100% |
A0A3Q8IHJ8 | Leishmania donovani | 97% | 100% |
A4HHV3 | Leishmania braziliensis | 90% | 100% |
A4I503 | Leishmania infantum | 96% | 100% |
C9ZQF2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 93% |
Q4Q7U8 | Leishmania major | 95% | 100% |